Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $57.7M
Liabilities Breakdown FY2013
Total Liabilities: $42.9M
Asset Breakdown
Total Assets: $57.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.5M | 9.5% |
| Accounts Receivable | $575.9K | 1.0% |
| Inventory | $178.7K | 0.3% |
| Property, Plant & Equipment | $3.0M | 5.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $46.2M | 80.0% |
| Other Assets | $2.3M | 3.9% |
Liabilities Breakdown
Total Liabilities: $42.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.4M | 8.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $39.5M | 92.0% |